mechlorethamine and porfiromycin

mechlorethamine has been researched along with porfiromycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, RF; Denny, WA; Hogg, A; Lee, AE; Lee, HH; Siim, BG; Tercel, M; Wilson, WR1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Selawry, OS1

Reviews

1 review(s) available for mechlorethamine and porfiromycin

ArticleYear
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:2

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Carcinoma, Bronchogenic; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Floxuridine; Humans; Hydroxyurea; Lung Neoplasms; Mechlorethamine; Methotrexate; Mitomycins; Nitrosourea Compounds; Plicamycin; Porfiromycin; Procarbazine; Streptonigrin; Thiotepa; Vinblastine

1973

Other Studies

2 other study(ies) available for mechlorethamine and porfiromycin

ArticleYear
Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Journal of medicinal chemistry, 2001, Oct-11, Volume: 44, Issue:21

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Hypoxia; Cell Line; Cell Survival; Comet Assay; Cricetinae; Cross-Linking Reagents; DNA; Drug Screening Assays, Antitumor; Humans; Imidazoles; Maximum Tolerated Dose; Mice; Neoplasm Transplantation; Nitro Compounds; Nitrogen Mustard Compounds; Oxidation-Reduction; Prodrugs; Quaternary Ammonium Compounds; Tumor Cells, Cultured

2001
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008